About this document
Glucocorticoid Management in SLE by Sandra Del Pilar Vicente is a document available to read on EtoBox.
The document discusses the use and effects of glucocorticoids (GCs), powerful anti-inflammatory drugs. GCs act through genomic and non-genomic pathways, with the genomic pathway responsible for many adverse effects. Observational studies link GCs to damage in systemic lupus erythematosus. While high GC doses clearly work, medium doses seem effective for severe SLE with fewer side effects. Daily doses under 7.5 mg of prednisone may minimize harm.
- Author
- Sandra Del Pilar Vicente
- Language
- EN